A Phase 4 Multicenter, Open-Label, Pilot Study Of Pregabalin And Prediction Of Treatment Response In Patients With Postherpetic Neuralgia

Trial Profile

A Phase 4 Multicenter, Open-Label, Pilot Study Of Pregabalin And Prediction Of Treatment Response In Patients With Postherpetic Neuralgia

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 05 Sep 2014

At a glance

  • Drugs Pregabalin (Primary)
  • Indications Postherpetic neuralgia
  • Focus Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 26 Apr 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 20 Feb 2013 Planned end date changed from 1 Oct 2013 to 31 Oct 2013 as reported by Oregon Health and Science University Institutional Review Board.
    • 05 Jan 2013 New source identified and integrated (IRB00008665: Oregon Health and Science University Institutional Review Board).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top